New Key Statistics Module, Z-Score and F-Score
NAS:CTOR Key Ratios
| Market Cap $ M | 102.51 |
| Enterprise Value $ M | 93.06 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 9.40 |
| Price/Book | 2.47 |
| Price/Sales | 12.36 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 7.00 |
| EPS (TTM) $ | -0.47 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.05 |
| EV-to-EBITDA | -2.26 |
| PEG | -- |
| Shares Outstanding M | 105.76 |
| Net Margin (%) | -648.35 |
| Operating Margin % | -665.66 |
| Pre-tax Margin (%) | -645.66 |
| Quick Ratio | 0.34 |
| Current Ratio | 0.73 |
| ROA % (ttm) | -44.69 |
| ROE % (ttm) | -108.99 |
| ROIC % (ttm) | -65.64 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.94 |
CTOR Number of Guru Trades
CTOR Volume of Guru Trades
Gurus Latest Trades with NAS:CTOR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTOR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Citius Oncology Inc Insider Transactions
No Available Data
News about NAS:CTOR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers